Chemical Structure (Clonidine 01)
Clonidine Patch, Extended Release
Product Images NDC 51862-455
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Clonidine (NDC 51862-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Clonidine 02)
This appears to be a list of components for a drug delivery system or patch. The system includes a backing, drug reservoir, control membrane, adhesive, and a slit release liner.*
Figure 1 (Clonidine 03)
Figure 2 (Clonidine 04)
This is a medication label for a transdermal patch containing Clonidine, which is a medication used to treat high blood pressure and attention deficit hyperactivity disorder (ADHD). The patch contains 0.1mg of Clonidine and is meant to be applied daily. The label also includes a lot number (NDCS1862453.01) and information on how to store the patch.*
Figure 2 (Clonidine 05)
Clonidine Transdermal System, USP is a medication that is designed to be administered through the skin in order to deliver clonidine to the body. It is commonly used to treat high blood pressure (hypertension) and attention deficit hyperactivity disorder (ADHD). The medication is also sometimes used to treat symptoms of withdrawal from opioids or nicotine. However, this brief text only provides the name of the medication, so it can only be used as an identification tool rather than as a detailed description of the drug.*
Figure 3 (Clonidine 06)
Figure 4 (Clonidine 07)
Figure 5 (Clonidine 08)
Figure 6 (Clonidine 09)
Clonidine Transdermal System, USP is a medication delivered via a patch applied to the skin to help manage hypertension. It works by reducing the nerve impulses that signal blood vessels to constrict, allowing blood vessels to relax and lowering blood pressure.*
Principal Display Panel (0.1 mg Patch Pouch Carton)
This is a product description for Clonidine Transdermal System USP, which is a medication patch used for programmed delivery of 0.1 mg of Clonidine per day for one week. Each system contains 3.09 mg of Clonidine. The text warns users to remove the patch before undergoing an MRI procedure to avoid possible burns. The text provides storage instructions to keep the medication at a controlled room temperature of 20°-25°C (68-77°F) and advises to keep all medications out of the reach of children. The manufacturer is Mayne Pharma.*
Principal Display Panel (0.2 mg Patch Pouch Carton)
Clonidine Transdermal System USP is a skin patch that delivers 0.2 mg of medication per day for one week. The patch should be removed before undergoing an MRI procedure to avoid possible burns. The pack contains 4 systems and 4 adhesive covers and should be stored at a temperature of 25°C. The product is manufactured for Mayne Pharma and made in Italy. The package insert contains additional prescribing information. Keep out of reach of children.*
Principal Display Panel (0.3 mg Patch Pouch Carton)
Clonidine Transdermal System USP is a medication that comes in a patch form. Each patch contains 0.28 mg of clonidine and is designed to deliver 0.3 mg per day for one week. The patch is programmed to release the medication in a controlled manner and is meant to be stored at room temperature. It is important to keep the patch out of reach of children and to remove it before undergoing any imaging procedures that use magnetic resonance. This product is manufactured by Mayne Pharma and is available in a package that includes four systems and four adhesive covers.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
